Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
7Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Repligen Corporation (RGEN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
14Total relationships
3Distinct source URLs
5High confidence
0.784Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
oving yields. We are committed to inspiring advances in bioprocessing as a trusted partner in the production of critical biologic drugs – including monoclonal antibodies (“mAbs”) and mAb derivatives …
Reciprocal relationship from MASS graph: Reciprocal relationship from RGEN graph: oving yields. We are committed to inspiring advances in bioprocessing as a trusted partner in the production of criti…
uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific Inc., MilliporeSigma and Sartorius. Many of our competitors are large, well-capital…
Reciprocal relationship from TMO graph: Reciprocal relationship from RGEN graph: uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific In…
Repligen Corporation Customers
Ticker
Name
Confidence
Evidence
USGOV-DEPARTMENT-OF-DEFENSE
USGOV-DEPARTMENT-OF-DEFENSE
95%
USAspending awards from Department of Defense: $48,742 across 1 awards. HT942524P0046 EQUIPMENT KR2I TFF SYSTEM - KF COMM 2 FOR THE WALTER REED ARMY INSTITTUE OF RESEARCH (WRAIR) | Qwen corrected dir…
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES
95%
USAspending awards from Department of Health and Human Services: $14,372,753 across 1 awards. 75A50121P00074 PHARMACEUTICAL CONSUMABLES EXPANSION AND ACCELERATION: SINGLE USE BAGS, ASSEMBLIES, AND TU…
ernal Control Over Financial Reporting We have audited Repligen Corporation’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control—Inte…
Reciprocal relationship from MASS graph: Reciprocal relationship from RGEN graph: Reciprocal relationship from MASS graph: Reciprocal relationship from RGEN graph: ernal Control Over Financial Report…
uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific Inc., MilliporeSigma and Sartorius. Many of our competitors are large, well-capital…
Reciprocal relationship from TMO graph: Reciprocal relationship from RGEN graph: Reciprocal relationship from TMO graph: Reciprocal relationship from RGEN graph: uct categories as well as several lar…
TANTTI-LABORATORY-INC
TANTTI-LABORATORY-INC
62%
S.”) Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or…
Repligen Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
RGEN-DEBT-12156
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
RGEN-DEBT
Debt stack $551.0M
90%
Market cache reports total debt of $551.0M.
Repligen Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Repligen Corporation.
Repligen Corporation Ownership
Holder
Name
Confidence
Evidence
RGEN-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 446 tracked holders.
